ICD-10-CM CATEGORY CODE RANGE SPECIFIC CONDITION ICD-10 CODE Diseases of the Circulatory System I00 –I99 Essential hypertension I10 Unspecified atrial fibrillation I48.91 Diseases of the Respiratory System J00 –J99 Acute pharyngitis, NOS J02.9 Acute upper respiratory infection J06._ Acute bronchitis, *,unspecified J20.9 Vasomotor rhinitis J30.0
Search the full ICD-10 catalog by:
The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
ICD-10-CM Diagnosis Codes
A00.0 | B99.9 | 1. Certain infectious and parasitic dise ... |
C00.0 | D49.9 | 2. Neoplasms (C00-D49) |
D50.0 | D89.9 | 3. Diseases of the blood and blood-formi ... |
E00.0 | E89.89 | 4. Endocrine, nutritional and metabolic ... |
F01.50 | F99 | 5. Mental, Behavioral and Neurodevelopme ... |
Mitochondrial diseases are long-term, genetic, often inherited disorders that occur when mitochondria fail to produce enough energy for the body to function properly. One in 5,000 individuals has a genetic mitochondrial disease. Symptoms, diagnosis and treatment are discussed.
Together, Leigh syndrome and MELAS are the most common mitochondrial myopathies. The prognosis of Leigh syndrome is generally poor, with survival generally being a matter of months after disease onset.
Common clinical features of mitochondrial disorders include ptosis, external ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes mellitus.
Types of Mitochondrial DiseasesAlper's Disease. Autosomal Dominant Optic Atrophy (ADOA) Barth Syndrome. ... Chronic Progressive External Ophthalmoplegia (CPEO) Co-Enzyme Q10 Deficiency. Creatine Deficiency Syndromes. ... Friedreich's Ataxia. Kearns-Sayre Syndrome (KSS) Lactic Acidosis. ... Leigh Syndrome. MELAS. Mitochondrial Myopathy.
Mitochondrial diseases are not contagious, and they are not caused by anything a person does. They're caused by mutations, or changes, in genes — the cells' blueprints for making proteins.
Mitochondrial DAMPs are important in triggering and maintaining immune responses. Mitochondrial dysfunction may play a role in the pathophysiology of autoimmune disease.
Parkinson's disease (PD) is a complex neurodegenerative disorder, the aetiology of which is still largely unknown. Overwhelming evidence indicates that mitochondrial dysfunction is a central factor in PD pathophysiology.
The main symptoms of mitochondrial myopathy are muscle fatigue, weakness, and exercise intolerance. The severity of any of these symptoms varies greatly from one person to the next, even in the same family. In some individuals, weakness is most prominent in muscles that control movements of the eyes and eyelids.
They found that a large number of lupus patients had red blood cells with detectable levels of mitochondria—and these cells were especially frequent in patients with the most severe lupus symptoms. By contrast, healthy controls had no mitochondria-containing red blood cells.
Mitochondrial diseases are a group of metabolic disorders. Mitochondria are small structures that produce energy in almost all of your cells. They make it by combining oxygen with the fuel molecules (sugars and fats) that come from your food.
Genetic testing is essential for the diagnosis of mitochondrial diseases. Next generation sequencing with gene dosage of nDNA and mtDNA in blood or affected tissues (muscle, buccal swab, urine sediment, liver biopsy) is recommended over testing for specific point mutations in cases of suspected mitochondrial disease.
They make it by combining oxygen with the fuel molecules (sugars and fats) that come from your food. When the mitochondria are defective, the cells do not have enough energy. The unused oxygen and fuel molecules build up in the cells and cause damage. The symptoms of mitochondrial disease can vary.
E88.40 is a billable diagnosis code used to specify a medical diagnosis of mitochondrial metabolism disorder, unspecified . The code E88.40 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.